J3379 Injection, valproate sodium, 5 mg
Billable / valid for submission HCPCS Release 2026Q3
Short description: Inj, valproate sod, 5 mg
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| 2026Q3 | 2026-07-01 | current | Injection, valproate sodium, 5 mg | yes |
Related codes in J33
- J3300 Injection, triamcinolone acetonide, preservative free, 1 mg
- J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
- J3302 Injection, triamcinolone diacetate, per 5 mg
- J3303 Injection, triamcinolone hexacetonide, per 5 mg
- J3304 Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
- J3315 Injection, triptorelin pamoate, 3.75 mg
- J3316 Injection, triptorelin, extended-release, 3.75 mg
- J3350 Injection, urea, up to 40 gm
- J3357 Ustekinumab, for subcutaneous injection, 1 mg
- J3358 Ustekinumab, for intravenous injection, 1 mg
- J3360 Injection, diazepam, up to 5 mg
- J3373 Injection, vancomycin hydrochloride, 10 mg
- J3374 Injection, vancomycin hydrochloride (mylan) not therapeutically equivalent to j3373, 10 mg
- J3375 Injection, vancomycin hydrochloride (tyzavan), not therapeutically equivalent to j3373, 10 mg
- J3376 Injection, vancomycin hcl (hikma), not therapeutically equivalent to j3373, 10 mg
- J3380 Injection, vedolizumab, intravenous, 1 mg
- J3385 Injection, velaglucerase alfa, 100 units
- J3386 Injection, etuvetidigene autotemcel, per treatment
- J3387 Injection, elivaldogene autotemcel, per treatment
- J3389 Topical administration, prademagene zamikeracel, per treatment